SCHEMBL488482

SCHEMBL488482

C=CC(O)NC(=O)/C=C/C

nearest known ligand 0.41

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.41
ALDH1A1 P00352 2/20 0.35
TP53 P04637 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
GAA P10253 1/20 0.34
ACACB O00763 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL327708 0.81
SCHEMBL5176317 0.75
SCHEMBL11173381 0.72 TSHR (0.45) TSHRALDH1A1
SCHEMBL16532739 0.72
SCHEMBL366041 0.72
SCHEMBL3708387 0.72
SCHEMBL3708388 0.72
SCHEMBL1563397 0.71 ALDH1A1 (0.40) TSHRALDH1A1TP53L3MBTL1GAA
SCHEMBL7802686 0.71 LMNA (0.35) TSHR
SCHEMBL9067167 0.71 LMNA (0.35) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 163 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11999865-B2 UV curable composition for use in 3D printing BASF SE (DE) 2024-06-04 US disclosed
EP-3856856-B1 UV CURABLE COMPOSITION FOR USE IN 3D PRINTING BASF SE (DE) 2024-05-29 EP disclosed
US-11897995-B2 Allophanate based dispersing agent BASF SE (DE) 2024-02-13 US disclosed
EP-4041830-B1 THERMALLY CURABLE TWO-COMPONENT COATING COMPOUNDS BASF SE (DE) 2023-12-06 EP disclosed
EP-3911687-B1 LIMONENE-BASED (METH)ACRYLATES FOR USE IN 3D PRINTING BASF SE (DE) 2023-11-01 EP disclosed
EP-3870618-B1 AQUEOUS BINDER FORMULATION BASED ON FUNCTIONALIZED POLYURETHANES BASF SE (DE) 2023-07-12 EP disclosed
US-20230002631-A1 WATER-WASHABLE COMPOSITIONS FOR USE IN 3D PRINTING BASF SE (DE) 2023-01-05 US disclosed
EP-4041830-A1 THERMALLY CURABLE TWO-COMPONENT COATING COMPOUNDS BASF SE (DE) 2022-08-17 EP disclosed
CN-114502668-A Thermally curable two-component coating composition 巴斯夫欧洲公司 2022-05-13 CN disclosed
US-20220064350-A1 LIMONENE-BASED (METH)ACRYLATES FOR USE IN 3D PRINTING BASF SE (DE) 2022-03-03 US disclosed
WO-2003068869-A2 COATINGS FOR CARRIER MATERIALS FOR MAKING AN OXYGEN BARRIER BASF AKTIENGESELLSCHAFT (DE) 2003-08-21 WO disclosed
US-20030153673-A1 Curable aqueous polyurethane dispersions BASF AKTIENGESELLSCHAFT (DE) 2003-08-14 US disclosed
WO-2003060029-A2 RADIATION-HARDENED COATINGS WITH IMPROVED ADHESIVE STRENGTH BASF AKTIENGESELLSCHAFT (DE) 2003-07-24 WO disclosed
EP-1294788-A1 CURABLE AQUEOUS POLYURETHANE DISPERSIONS BASF AKTIENGESELLSCHAFT (DE) 2003-03-26 EP disclosed
WO-2002086000-A1 UNSATURATED COMPOUNDS CONTAINING CARBAMATE TERMINAL GROUPS OR UREA TERMINAL GROUPS BASF AKTIENGESELLSCHAFT (DE) 2002-10-31 WO disclosed
EP-1224234-A1 AQUEOUS POLYURETHANE DISPERSIONS WHICH CAN BE HARDENED WITH MIT UV-RADIATION AND THERMALLY, AND USE THEREOF BASF AKTIENGESELLSCHAFT (DE) 2002-07-24 EP disclosed
WO-2002000754-A1 CURABLE AQUEOUS POLYURETHANE DISPERSIONS BASF AKTIENGESELLSCHAFT (DE) 2002-01-03 WO disclosed
EP-1144476-A1 COATING AGENTS WHICH CAN BE HARDENED BY THE ADDITION OF ISOCYANATE GROUPS AS WELL AS BY THE RADIATION-INDUCED ADDITION OF ACTIVATED C-C DOUBLE COVALENT BONDS BASF AKTIENGESELLSCHAFT (DE) 2001-10-17 EP disclosed
WO-2001023453-A1 AQUEOUS POLYURETHANE DISPERSIONS WHICH CAN BE HARDENED WITH MIT UV-RADIATION AND THERMALLY, AND USE THEREOF BASF AKTIENGESELLSCHAFT (DE) 2001-04-05 WO disclosed
WO-2000039183-A1 COATING AGENTS WHICH CAN BE HARDENED BY THE ADDITION OF ISOCYANATE GROUPS AS WELL AS BY THE RADIATION-INDUCED ADDITION OF ACTIVATED C-C DOUBLE COVALENT BONDS BASF AKTIENGESELLSCHAFT (DE) 2000-07-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220064350-A1 LIMONENE-BASED (METH)ACRYLATES FOR USE IN 3D PRINTING LIMK1, LIMA1, LIMK2 TSHR 3518/4885ALDH1A1 169/4885TP53 1460/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.